SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Thomas Jefferson

PatientThomas Jefferson
Date of birth1979-04-13
IdentifiersMRN HR-EN005-SYN; SSN (made up) 000-05-2276
Document date2026-05-21
AuthorNathaniel Beaumont-Ruiz, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review of the headache diary, seen the same day by headache medicine. [S]

History of Present Illness

Mr. Jefferson returns with his 14-day headache diary and is seen by Dr. Haddad of headache medicine on the same day. The bout that began three weeks ago has eased. His diary shows headache on 7 of 14 days: each attack began between nine and ten in the morning, built over an hour to a moderate or severe throbbing pain across the forehead and temples, worse with reading and climbing stairs, with sensitivity to light and noise on every headache day and nausea on four, and lasted six to ten hours, settling by evening. He had no visual or other aura. The last seven days have been headache-free. He took naproxen on four days, with metoclopramide on two, and the pain was reduced but rarely gone after two hours; he has taken no combination analgesic since intake. Counting the week before intake, he has had 13 migraine days in the past four weeks. He has been sleeping six hours, has kept to two cups of coffee and has not skipped lunch. He has had no weakness, numbness, fever or change in vision. [S]

ElementDetail
DiaryHeadache on 7 of 14 days; morning onset, six to ten hours, throbbing, light and noise sensitivity, nausea on four days; no aura
Past four weeks13 migraine days
Acute medicineNaproxen on four days, metoclopramide on two; partial relief
Combination analgesicNone since intake
Red flagsNone

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or weight loss
EyesNegativeNo visual aura or loss of vision
NeurologicalPositiveMigraine attacks as in the diary; no weakness, numbness or speech change
PsychiatricNegativeFrustrated by lost work; mood otherwise steady

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a weekOne tablet at headache onset, may repeat once after 12 hours; no more than two days a weekOral route2026-05-07activeS
Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a weekOne tablet with the acute medicine when nausea is present, no more than once a dayOral route2026-05-07activeS
Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a monthOne tablet at attack onset with naproxen, may repeat once after 2 hours; up to 200 mg a dayOral route2026-05-21activeS
Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine preventionOne capsule each eveningOral route2026-05-21 to 2026-06-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-21Body height189cmS
2026-05-21Body weight76.2kgS
2026-05-21Body mass index (BMI) [Ratio]21.3kg/m2S
2026-05-21Systolic blood pressure122mm[Hg]S
2026-05-21Diastolic blood pressure78mm[Hg]S
2026-05-21Heart rate70/minS
2026-05-21Respiratory rate14/minS
2026-05-21Body temperature36.6CelS
2026-05-21Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 2026-05-21; see the Vital Signs section. [S]

SystemFinding
GeneralComfortable today; blood pressure 122/78, pulse 70
EyesFundi with sharp discs; visual fields full
NeurologicalCranial nerves, strength, sensation, reflexes, coordination and gait normal
Head and neckMild tenderness of the neck and shoulder muscles; temporal arteries normal

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent disabling headaches since early adulthood, in bouts lasting days to weeks, now in the seventh day of a bout; under evaluation, with a two-week headache diary and a headache medicine consultation; no red flagsresolvedconfirmed R51.9S — Synthetic presenting problem anchored to his documented periodical headaches; superseded when the consultation confirmed migraine without aura.
Migraine without aura, episodic, with bouts of near-daily attacks lasting two to three weeks; ICHD-3 criteria met in a two-week diary; synthetic modern diagnosis linked to his documented periodical headaches, which historians have usually but not unanimously called migraineactiveconfirmed G43.009S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0013), so this is not a claim about his real diagnosis.
Stiffness and weakness of the right wrist and hand after a dislocation that healed out of place in early middle age; writing is slow and painful after about an houractiveconfirmed M25.631S — Synthetic modern coding of the documented badly healed right wrist dislocation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationRed-flag screen (SNNOOP10): systemic signs, neurological signs, sudden or new pattern, onset after 50, positional or Valsalva features, papilledema, progressive courseEvery visitCompleted todayNo red flags; normal neurological examination and fundi
SurveyHeadache diary: headache and migraine days, attack features, triggersEvery visitCompleted today14 days kept: headache on the first 7 days, all meeting migraine features; 13 migraine days in the past four weeks
Medication safetyAcute-medicine days (medication overuse headache limits: triptan fewer than 10, NSAID fewer than 15 days a month)Every visitCompleted todayNaproxen on four days in 14; no combination analgesic since intake
Medication safetyAcute treatment response (pain-free at two hours, return to work)Every visitCompleted todayNaproxen gave partial relief, rarely pain-free at two hours; triptan added
Medication safetyCardiovascular screen before a triptanBefore the first triptan prescriptionCompleted todayNo chest pain, vascular disease, uncontrolled blood pressure or smoking; blood pressure 122/78
Medication safetyPropranolol tolerability: pulse, blood pressure, tiredness, exercise tolerance, wheeze, cold hands, sleepFour weeks after starting or changing the dose, then each visitCompleted todayBefore starting: pulse 70, blood pressure 122/78; no asthma, heart block or depression
ExaminationPreventive efficacy (at least 50% fewer migraine days)At two to three months on an adequate doseDuePropranolol started today; efficacy judged at the three-month review
SurveyDisability (MIDAS, recorded as its five items, and HIT-6)At baseline and after about three months of preventionUp to dateMIDAS 39 (grade IV) and HIT-6 66 at intake; repeat at three months
SurveyMood (PHQ-9) and anxiety (GAD-7), including on a beta-blockerAt baseline, four to six weeks after starting a preventive that can affect mood, then at each reviewUp to datePHQ-9 6 and GAD-7 7 at intake; repeat four to six weeks after starting propranolol
ImagingNeuroimagingOnly for red flags or a change in patternNot indicatedStable pattern for more than twenty years, normal examination, no red flags
Self-managementSleep, meals, caffeine and work-stress planEvery visitCompleted todaySix hours of sleep, two cups of coffee, regular lunch
ReferralHeadache medicine consultationAt diagnosisCompleted todaySeen by Dr. Haddad today
ReferralOccupational therapy visit for the right wrist and writingWithin four weeks of intakeOrderedRequested at intake; awaiting an appointment

Goal progress:

Guideline basis: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024); The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019); Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013)

Follow-up: Six-week review in four weeks. Diary continued. Call for a headache unlike his usual attacks, weakness, numbness, fever or a stiff neck. Next scheduled visit 2026-06-18: six-week review, four weeks after starting propranolol: tolerability, attacks, acute medicine days and the wrist. [S]